Association of Lumbar Puncture With Spinal Hematoma in Patients With and Without Coagulopathy.
Adolescent
Adult
Aged
Aged, 80 and over
Blood Coagulation Disorders
/ blood
Cerebrospinal Fluid
/ chemistry
Child
Cohort Studies
Denmark
/ epidemiology
Female
Hematoma
/ etiology
Humans
International Normalized Ratio
Male
Middle Aged
Partial Thromboplastin Time
Proportional Hazards Models
Registries
/ statistics & numerical data
Risk Factors
Spinal Diseases
/ etiology
Spinal Puncture
/ adverse effects
Thrombocytopenia
/ epidemiology
Time Factors
Young Adult
Journal
JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160
Informations de publication
Date de publication:
13 10 2020
13 10 2020
Historique:
entrez:
13
10
2020
pubmed:
14
10
2020
medline:
23
10
2020
Statut:
ppublish
Résumé
Coagulopathy may deter physicians from performing a lumbar puncture. To determine the risk of spinal hematoma after lumbar puncture in patients with and without coagulopathy. Danish nationwide, population-based cohort study using medical registries to identify persons who underwent lumbar puncture and had cerebrospinal fluid analysis (January 1, 2008-December 31, 2018; followed up through October 30, 2019). Coagulopathy was defined as platelets lower than 150 × 109/L, international normalized ratio (INR) greater than 1.4, or activated partial thromboplastin time (APTT) longer than 39 seconds. Coagulopathy at the time of lumbar puncture. Thirty-day risk of spinal hematoma. Risks were provided as numbers and percentages with 95% CIs. Secondary analyses included risks of traumatic lumbar puncture (>300 × 106 erythrocytes/L after excluding patients diagnosed with subarachnoid hemorrhage). Adjusted hazard rate ratios (HRs) were computed using Cox regression models. A total of 83 711 individual lumbar punctures were identified among 64 730 persons (51% female; median age, 43 years [interquartile range, 22-62 years]) at the time of the procedure. Thrombocytopenia was present in 7875 patients (9%), high INR levels in 1393 (2%), and prolonged APTT in 2604 (3%). Follow-up was complete for more than 99% of the study participants. Overall, spinal hematoma occurred within 30 days for 99 of 49 526 patients (0.20%; 95% CI, 0.16%-0.24%) without coagulopathy vs 24 of 10 371 patients (0.23%; 95% CI, 0.15%-0.34%) with coagulopathy. Independent risk factors for spinal hematoma were male sex (adjusted hazard ratio [HR], 1.72; 95% CI, 1.15-2.56), those aged 41 through 60 years (adjusted HR, 1.96; 95% CI, 1.01-3.81) and those aged 61 through 80 years (adjusted HR, 2.20; 95% CI, 1.12-4.33). Risks did not increase significantly according to overall severity of coagulopathy, in subgroup analyses of severity of coagulopathy by pediatric specialty or medical indication (infection, neurological condition, and hematological malignancy), nor by cumulative number of procedures. Traumatic lumbar punctures occurred more frequently among patients with INR levels of 1.5 to 2.0 (36.8%; 95% CI, 33.3%-40.4%), 2.1 to 2.5 (43.7%; 95% CI, 35.8%-51.8%), and 2.6 to 3.0 (41.9% 95% CI 30.5-53.9) vs those with normal INR (28.2%; 95% CI, 27.7%-28.75%). Traumatic spinal tap occurred more often in patients with an APTT of 40 to 60 seconds (26.3%; 95% CI, 24.2%-28.5%) vs those with normal APTT (21.3%; 95% CI, 20.6%-21.9%) yielding a risk difference of 5.1% (95% CI, 2.9%-7.2%). In this Danish cohort study, risk of spinal hematoma following lumbar puncture was 0.20% among patients without coagulopathy and 0.23% among those with coagulopathy. Although these findings may inform decision-making about lumbar puncture by describing rates in this sample, the observed rates may reflect bias due to physicians selecting relatively low-risk patients for lumbar puncture.
Identifiants
pubmed: 33048155
pii: 2771609
doi: 10.1001/jama.2020.14895
pmc: PMC8094417
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1419-1428Commentaires et corrections
Type : CommentIn
Type : CommentIn
Références
Can J Anaesth. 1996 Dec;43(12):1260-71
pubmed: 8955979
Anesthesiology. 2004 Oct;101(4):950-9
pubmed: 15448529
Stroke. 1981 Nov-Dec;12(6):879-81
pubmed: 7303081
Mayo Clin Proc. 2019 Aug;94(8):1552-1555
pubmed: 31378231
Anesth Analg. 1986 Nov;65(11):1201-7
pubmed: 3767019
Ann Hematol. 2003 Sep;82(9):570-3
pubmed: 12904898
Anesth Analg. 2010 Nov;111(5):1322-4
pubmed: 20705781
Br J Anaesth. 2009 Feb;102(2):179-90
pubmed: 19139027
Cochrane Database Syst Rev. 2018 Apr 30;4:CD011980
pubmed: 29709077
Br J Anaesth. 2008 Dec;101(6):832-40
pubmed: 18945716
Br J Haematol. 2007 Jan;136(2):347-8
pubmed: 17156399
Cancer. 1982 May 15;49(10):2168-72
pubmed: 7074532
JAMA. 2000 Nov 1;284(17):2222-4
pubmed: 11056594
Lancet. 2018 Mar 24;391(10126):1197-1204
pubmed: 29223694
Br J Haematol. 2004 Feb;124(4):433-53
pubmed: 14984493
Br J Haematol. 2003 Jul;122(1):10-23
pubmed: 12823341
Anesth Analg. 1994 Dec;79(6):1165-77
pubmed: 7978443
Ann Intern Med. 2015 Feb 3;162(3):205-13
pubmed: 25383671
Reg Anesth Pain Med. 2018 Apr;43(3):263-309
pubmed: 29561531
Br J Haematol. 2004 Oct;127(2):233-4; author reply 234-5
pubmed: 15461636
Arch Neurol. 1974 Aug;31(2):134-7
pubmed: 4525944
Neurosurg Rev. 2003 Jan;26(1):1-49
pubmed: 12520314
Anesthesiology. 2007 May;106(5):997-1002
pubmed: 17457132
Anesthesiology. 2006 Aug;105(2):394-9
pubmed: 16871074
N Engl J Med. 1981 Apr 23;304(17):1020-1
pubmed: 7207553
Clin Epidemiol. 2015 Nov 17;7:449-90
pubmed: 26604824
Eur J Epidemiol. 2014 Aug;29(8):541-9
pubmed: 24965263
Scand J Public Health. 2011 Jul;39(7 Suppl):26-9
pubmed: 21775346
Mayo Clin Proc. 2018 May;93(5):627-629
pubmed: 29573815
Eur Neurol. 2016;76(1-2):8-11
pubmed: 27336667
J Infect. 2016 Apr;72(4):405-38
pubmed: 26845731
Transfus Med Hemother. 2009;36(6):372-382
pubmed: 21245968